A simple vaso-occlusion model for SCD drug discovery
A simple vaso-occlusion model for SCD drug discovery
批准号:
7067050
负责人:
TIMOTHY C FISHER
金额:
$12.19万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-26 至 2007-07-31
关键词:
AfricanAfrican Americanblood disorder chemotherapyblood vessel occlusioncardiovascular disorder preventionchemopreventionclinical researchdisease /disorder modeldrug discovery /isolationdrug screening /evaluationerythrocyteshigh throughput technologyhuman subjectmethod developmentmolecular /cellular imagingpatient oriented researchsickle cell anemia
中文摘要
描述(申请人提供):自发现导致镰状细胞病(SCD)的分子缺陷以来的55年里,研究人员一直在寻找抗镰刀药物来预防疾病的并发症,但收效甚微。然而,由于现有技术的限制,在这段时间内可以评估的不同化合物的总数肯定相对较少。最近,自动化高通量筛选(HTS)使快速筛选数十万种不同小分子的文库成为可能,从而找到有前途的候选药物或可能的药物开发新靶点。目前,还没有适合HTS的直效抗镰刀剂的检测方法。使用S血红蛋白溶液的分析方法简单,易于自动化,但不涉及药物摄取或红细胞中任何其他可能的靶点,而红细胞完整的形态镰刀样分析速度慢,难以自动化和标准化。这项研究的目的是开发一种简单而稳健的HTS兼容的384孔筛查方法,该方法基于简化的血管闭塞模型。该分析方法测量Sephacryl柱中珠子之间形成的狭窄通道中脱氧红细胞的捕获,并具有简单而稳定的终点,可通过光学成像读取。初级筛查将检测红细胞是被捕获的(阴性结果)还是穿过凝胶(阳性的“抗镰刀”结果)。二次化验将测量活性(剂量-反应),并检查每一次“击中”的作用机制。开发阶段将是:检查所有重要的分析变量的贡献,特别是测试红细胞的变化的影响;制定健壮、可重复和灵敏的最佳分析和方案;制定质量控制程序,以确保测试红细胞的可重复性能;最后,在半自动筛选>;1500化合物期间测试和进一步完善分析和程序,以模拟高温超导环境中的分析使用。
英文摘要
DESCRIPTION (provided by applicant): In the 55 years since the molecular defect responsible for sickle cell disease (SCD) was discovered, researchers have searched for anti-sickling agents to prevent the complications of the disease, but with little success. However, the total number of different chemical compounds that could have been evaluated over this period must be relatively small, due the limitations of the available technology. Recently, automated high throughput screening (HTS), has made it possible to rapidly screen libraries of hundreds of thousands of different small molecules to find promising drug candidates or possible new targets for drug development. At present, there are no assays for direct-acting anti-sickling agents that are well-suited for HTS. Assays that use hemoglobin S solutions are simple and amenable to automation, but do not address drug uptake or any other possible targets in the RBC, while morphologic sickling assays with intact RBCs are slow and difficult to automate and standardize. The aim of this study is to develop a simple and robust HTS compatible 384-well screening assay based upon a simplified model of vaso-occlusion. The assay measures the trapping of deoxygenated RBCs in the narrow channels formed between the beads in a Sephacryl column, and has a simple and stable endpoint that is read by optical imaging. The primary screen will detect whether the RBCs are trapped (the negative result) or pass through the gel (a positive "anti-sickling" result). Secondary assays will measure the activity (dose-response) and examine the mechanisms of action for each "hit". The phases of development will be: Examination of the contribution of all important assay variables, in particular, the influence of variation in the test RBCs; developing optimal assays and protocols that are robust, reproducible and sensitive; development of quality control procedures to insure reproducible performance of the test RBCs; and finally testing and further refinement of the assays and procedures during a semi-automated screen of >1500 compounds to simulate the use of the assays in a HTS environment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hemostatic-antibiotic Combination for Prevention of MRSA Surgical Site Infections
-
批准号:8001471
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2010
-
负责人:TIMOTHY C FISHER
-
依托单位:
Preclinical Development of an Absorbable Antibacterial Bone Hemostatic Agent
-
批准号:7612540
-
项目类别:
-
资助金额:$9.97万
-
财政年份:2009
-
负责人:TIMOTHY C FISHER
-
依托单位:
A simple vaso-occlusion model for SCD drug discovery
-
批准号:7127242
-
项目类别:
-
资助金额:$15.92万
-
财政年份:2005
-
负责人:TIMOTHY C FISHER
-
依托单位:
POLYMORPHISMSAND SEVERITYIN SICKLE CELL DISEASE
-
批准号:7001817
-
项目类别:
-
资助金额:$3.6万
-
财政年份:2004
-
负责人:TIMOTHY C FISHER
-
依托单位:
POLYMER-COATED RED BLOOD CELL FOR SICKLE CELL DISEASE
-
批准号:6190849
-
项目类别:
-
资助金额:$28.33万
-
财政年份:2000
-
负责人:TIMOTHY C FISHER
-
依托单位:
POLYMER-COATED RED BLOOD CELL FOR SICKLE CELL DISEASE
-
批准号:6527635
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2000
-
负责人:TIMOTHY C FISHER
-
依托单位:
POLYMER-COATED RED BLOOD CELL FOR SICKLE CELL DISEASE
-
批准号:6390878
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2000
-
负责人:TIMOTHY C FISHER
-
依托单位:
POLYMER-COATED RED BLOOD CELL FOR SICKLE CELL DISEASE
-
批准号:6650218
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2000
-
负责人:TIMOTHY C FISHER
-
依托单位:
POLYMORPHISMSAND SEVERITYIN SICKLE CELL DISEASE
-
批准号:7446745
-
项目类别:
-
资助金额:$2.9万
-
财政年份:--
-
负责人:TIMOTHY C FISHER
-
依托单位:
POLYMORPHISMSAND SEVERITYIN SICKLE CELL DISEASE
-
批准号:7246524
-
项目类别:
-
资助金额:$3.6万
-
财政年份:--
-
负责人:TIMOTHY C FISHER
-
依托单位:
POLYMORPHISMSAND SEVERITYIN SICKLE CELL DISEASE
-
批准号:7066624
-
项目类别:
-
资助金额:$3.6万
-
财政年份:--
-
负责人:TIMOTHY C FISHER
-
依托单位:
海外基金